Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
George I agree..$12 does nothing for me....
That's only like $3.8M. I have much bigger goals.
I'm sure there are lots of small BIOS with less O/S shares than IPIX.
But they all did 1 for 20 reverse Splits!!!!
Something that will NEVER happen with IPIX!!!!!
tic toc kaBooooooooooooOM!!!
If we could see top line for 199 patients in P in as little as 2-3 weeks or even a week then with only 42 patients George could be right that OM TOP line results could be ready this week. Though I'd love to see a Monday morning PRE-market announcement.
tic toc kaBoooooooooooooooooooooooooooooOM !!
Untohim Prurisol? Really? Read a little slower next time...
They are there for B not P...SHEEEEEEEEEEEEEEEEEEEEESH!!!!!
Brilacidin also exhibits strong anti-inflammatory effects on key effector cells involved in the etiology of Hidradenitis Suppurativa (HS), a burdensome skin disease affecting 1 to 4 percent of the world’s population, and for which there currently is only one approved marketed treatment (Humira).
Read Amatuer...Sheeeeesh
Treatment of the final subjects in the current Phase 2b Prurisol trial will be completed within the next 4 weeks before the end of November 2017!!!
Neither is this a creditable post................................
JTORENCE Friday, 10/27/17 03:08:47 PM
Re: None
Post #
201528
of 201709 Go
The way this is trading today. Could be we see the .70s again next week. imo.
Ziagen was prescribed up to 600mg without serious side effects for 25 years!!!!
300-400mg safety for Prurisol is a NO brainer.
Through one year, serious adverse events in the ultIMMa-1 and ultIMMa-2 trials occurred in 8 percent and 7 percent of patients in the continuous risankizumab group, respectively, compared to 11 percent and 7 percent of patients treated continuously with ustekinumab.1,2 In ultIMMa-2, one patient receiving risankizumab died from a sudden cardiac arrest 101 days after the last dose of study drug.2 A second patient receiving risankizumab died 161 days after the last dose, with cause of death unknown.2 Both patients had a past history of cardiovascular risk factors.2 There were no deaths in ultIMMa-1.1
Long term safety looks like a problem
Long term safety for Prurisol has already been proven over the last 20 years!!
If I signed a CNDA for Prurisol I would not let Leo release 6 week trial data.
George I wonder how much the World Wide market for OM will be for a PREVENTATIVE and not hokie Pokie treatments!!!
I say a lot more than $2.6B
Amatuer there will be NO phase 1 for any Brilacidin trials.
Everything starts at Phase2....Safety already established.
Sheeeeeeesh!
George a measly conservative price of $70 a pop per dose of B to PREVENT OM.
That's $10k per 7 week treatment.
Every 100,000 patients is a $BILLION.
B-OM is a prevention and a Goldmine!!!
Trial ends next week....OMG!!!!!!!!
Tic Toc kaBoooooooooooooOM
JTorence You don't need the inside scoop on the OM trial.
If 30 patients don't get OM then what would you think was the preventative?
A.Brilacidin or B. The Placebo
Think carefully...sheeeeeesh!
Prurisol trial is not complete until 12/15....Turkey day is a no go.
Om is only a $1 Billion market because
Ice Chips are cheap.
B-OM will bring in between $2-5 BILLION... BANK on it...
Cabel I assume you are talking about B-OM.
If so then there are 3 weeks left then data crunching starts.
Look at Monday's PR.
REVIVE-2 was a 600-patient double-blinded, active-controlled, global trial in patients with ABSSSI that compared the safety and efficacy of an 80mg intravenous dose of iclaprim with a 15mg/kg intravenous dose of vancomycin. Treatments were administered every 12 hours for 5 to 14 days.
Pffffff....
Nerby if this is indeed true then it would have to be Prurisol because there was NO activity at 6 weeks for the Placebo 2a.
How about posting her message to you?
B-OM will be the OM in...................................
KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM
Innovation is not testing biofilms..so I....
Wonder Why it is in the Infectious Disease Circle?
Somebody liked their results:)
http://www.ipharminc.com/therapeutic-areas/
Also note P and B for Eczema.....Gotta love INNOVATION!!!!!
Tic Toc Kabooooooooooooooooooooooooooom!!!
KarinCA approval for any Brilacidin indication will trigger jnj to move on biofilm...NOT only ABSSSI. You can bet that JNJ is 1 of the cnda's.
Email 2 years ago from Leo
"Hi xxx,
Once Brilacidin is approved for an indication, the approval process is relatively simple for them to market their items with Brilacidin. Meanwhile they are doing their studies on coating Brilacidin on their items."
sox040713 The dosing for B-OM is indeed complete. Now The 4 week wait....Then results before Turkey Day.
Don't forget BreakThrough Therapy Designation!
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!
Groton68 did you ever find where Leo said P would be the 1st drug partnership? I couldn't find it so I'll assume you are mistaken or just made it up.
After B-Om P2 trial is proven successful
B-Absssi will be sold. The BIG BIG money is in anti-inflammatory and Pro-Inflammatory and Biofilm.
Groton please show me where Leo said P would be the 1st partnership. I must have missed that....and I thought I was following my investment carefully...sheeeeesh on me!
Maybe whomever has the cnda on P doesn't want those results released to the world. It wouldn't be confidential anymore..Would it?
120 posts on a Saturday?
Life is to short for this BS....
Would that B remaining hope be for
Absssi
OM
Biofilms
UC
crohns
acne or
HS?
BTW There are only 2 sites for K....Sheeeeeesh!
10k is out....
I think the company wants them to stay....
"I predict, IPIX will be history by March or April 2018." I agree!!
I'm glad you think a buyout is coming also. I knew you would come to your senses!!!!
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO!!!
Ever wonder why we still don't know where the UP trial was run at?
Because it was at a BP trial site.......Deal in the works.....
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!!
JHawker That is not true. Brilacidin can be approved for ANY indication, antibiotic,anti-inflammatory,Pro-Inflammatory and it can then be used as a biofilm for the medical device unit of JNJ.
It's NOT just antibiotic......
Bluess44 Pictures of mice butts don't count! The JNJ $990m deal was preclinical!!!!!!!
Sure RDUNN dropouts and nobody interested....Well except for Dartmouth.
How about there are "7" phase2 trials at MaryCrowley going on right now for Ovarian Cancer. Some are for multiple cancers not strictly Ovarian, but none the less 7 trials for OC.
Enrollment is slow and Leo wants it done by EOY...Hence Dartmouth for Cohort b.
https://www.marycrowley.org/clinical-trials/?p=II&dt=Ovarian
So is $475,000 real and serious.
Leo knows whether P is working at 6 weeks or not without even unblinding the study. If you look at the charts from the 2a trial there was NO Placebo activity at 6 weeks. Placebo activity doesn't start until week 8. Any activity seen at 6 weeks or before in the 2B trial is CLEARLY Prurisol.
SOX The Placebo arm in phase2a did not show any activity until week 8.
It was FLATLINED at 6 weeks the entire time.
80% interim data is more than good enough.